NCT04641247 A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study Status RECRUITING Phase PHASE2
NCT04640311 Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants Status COMPLETED Phase PHASE1
NCT04634409 A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness Status COMPLETED Phase PHASE2
NCT04617925 A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis Status COMPLETED Phase PHASE2
NCT04617470 Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study Status UNKNOWN Phase N/A
NCT04607005 Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) Status COMPLETED Phase PHASE3
NCT04606394 Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD Status COMPLETED Phase PHASE4
NCT04605159 A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers Status TERMINATED Phase PHASE3
NCT04604795 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole Status COMPLETED Phase PHASE1
NCT04600752 Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India Status COMPLETED Phase PHASE4
NCT04585997 Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". Status UNKNOWN Phase PHASE4
NCT04585009 Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics Status COMPLETED Phase PHASE1
NCT04584255 Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04581824 Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Status TERMINATED Phase PHASE2
NCT04570306 Transcriptional and Immune Parameters of Response to Belimumab Status COMPLETED Phase N/A
NCT04557371 A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. Status COMPLETED Phase NA
NCT04551989 Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan Status COMPLETED Phase N/A
NCT04549363 Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin Status TERMINATED Phase PHASE3
NCT04545060 VIR-7831 for the Early Treatment of COVID-19 in Outpatients Status COMPLETED Phase PHASE2/PHASE3